ERBI CONFERENCE SPECIAL NEWSLETTER JUNE 2003

Dennis Camilleri gave a presentation to an audience of over 400 which included biotech scientists, commercial business development directors, technology transfer
executives and financial investors. This was helpful in promoting RBS and
increasing awareness and networking.

Extract from the Newsletter:

"Views from new companies and those not so new

The Second day of the conference included presentations from six new companies about their vision of the future. Speakers from Akubio, Daniolabs, Purely Proteins, Rapid Biosensors, TheraSci and Xention outlines their approach and plans for future development.

The other end of the spectrum was represented by pre IPO companies, which outlined their business strategy, with speakers from Amura, Cambridge Biotechnology, Ionix Pharmaceuticals, Isogenica, KuDOS Pharmaceuticals, Lorantis and Sirus."

NOTE: You can download the whole newsletter from the ERBI website using the item entitled Newsletter July 2003